Vascular Biogenics initiated with Buy rating
May 26, 2015 at 19:24 PM EDT
Barron's initiated coverage of Vascular Biogenics Ltd. (Nasdaq: VBLT) with a Buy rating and a $13 price target sending the stock price soaring $2.10 to close at $7.35.
